My watch list
my.bionity.com  
Login  

Inotek



Inotek Pharmaceuticals is a biotech company that previously entered patients for its phase II trial for its compound IND-001, for the prevention of cardiac necrosis. INO-1001 is a potent inhibitor of PARP.

It is based at Beverly, Massachusetts.

It is owned by a crazy man who lies, cheats and steals. Let's hope the Food and Drug Administration finds him and catches him.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Inotek". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE